BKR.NASDAQBaker Hughes CO

Form 4: Baker Hughes Executive Exercises, Sells Shares

Sentiment:

Insider Transaction Report


A Baker Hughes Co. executive exercised stock options and simultaneously sold an equal number of shares under a pre-arranged trading plan.

Summary

  • Maria C. Borras, Chief Growth & Experience Officer of Baker Hughes Co. (BKR), executed transactions on September 10, 2025.
  • Borras acquired 50,362 shares of Class A Common Stock by exercising stock options at a price of $36.89 per share.
  • Concurrently, Borras disposed of 50,362 shares of Class A Common Stock at a price of $46.89 per share.
  • These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Borras on March 7, 2025.
  • Following these transactions, Borras directly beneficially owns 116,643 shares of Class A Common Stock.
  • The stock options exercised were granted on July 31, 2017, and vested in three equal annual installments starting one year from the grant date, with an expiration date of July 31, 2027.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an executive selling shares might be seen negatively, the transaction was pre-planned under a 10b5-1 plan, indicating routine financial management rather than a reaction to new information. The executive also realized a profit from the option exercise.

Positives

  • The executive exercised stock options, indicating a realization of value from previously granted equity compensation.
  • The sale price of $46.89 per share is higher than the exercise price of $36.89, resulting in a profit for the executive on the exercised options.

Negatives

  • The executive sold a significant number of shares (50,362), which could be perceived as a reduction in direct ownership, although it was part of a pre-arranged plan.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing details an individual executive's equity transactions and does not provide broader industry context or trends. It reflects standard executive compensation and personal financial planning practices within a publicly traded company.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantMaria Claudia Borras granted a Power of Attorney to Georgia Magno, Fernando Contreras, and Mitchell Athey to prepare and file SEC Forms 3, 4, 5, and 144 on her behalf.2025-07-23Streamlines the process for the executive to comply with Section 16 reporting requirements, ensuring timely and accurate filings.

Related Party Transactions

  • The reported transactions involve an executive of Baker Hughes Co. exercising stock options and selling shares of the company, which is a standard form of related party transaction in the context of executive compensation.

Stakeholder Impact

  • Shareholders: The sale of shares by an executive, even under a 10b5-1 plan, could be viewed as a slight reduction in insider alignment, though the pre-planned nature mitigates negative interpretations. The profit realized by the executive from option exercise is a common outcome of equity compensation programs designed to align management interests with shareholders.
  • Employees: No direct impact on employees is indicated by this filing.
  • Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

DateDescription
2017-07-31Date stock option was granted.
2025-03-07Date the Rule 10b5-1 trading plan was adopted by the reporting person.
2025-07-23Effective date of the Power of Attorney granted by Maria Claudia Borras.
2025-09-10Date of the stock option exercise and subsequent sale of Class A Common Stock.
2025-09-12Date the Form 4 was signed by the attorney-in-fact.
2027-07-31Expiration date of the stock option.

Recommendation

hold

This Form 4 filing details a routine, pre-planned insider transaction (exercise of options and sale of shares) by an executive. It does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is consistent with personal financial management under a Rule 10b5-1 plan and does not suggest any significant positive or negative implications for the stock's fundamental value.

Keywords

Baker Hughes, BKR, SEC Form 4, Insider Trading, Stock Options, Equity Compensation, Rule 10b5-1 Plan, Executive Transactions, Maria C. Borras

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.